BNP Paribas Asset Management
DRNA

BNP Paribas Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

BNP Paribas Asset Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-42,794
Closed -$1.21M – 969
2014
Q1 		$1.21M Buy
+42,794
New +$1.21M 0.01% 738